Company intelligence / Profile preview

CX Therapeutics

Lowell or Boston area, Massachusetts, United Statescx-therapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CX Therapeutics has developed a novel medical device intended to improve the safety and effectiveness of cerclage procedures for treating cervical insufficiency and preventing preterm birth. The prototype device has undergone preclinical testing; no clinical trial results are yet available.

Therapeutic areas: Women's Health
Modalities: Device (medical device)
Industry: Surgical Medical Devices

Partnerships

Massachusetts Medical Device Development Center & Biotech Incubator (M2D2)Life Science Nation/RESI community connections for fundraising and partnering supportUniversity of Massachusetts Lowell-based programs via M2D2 accelerator support

Beyond the preview

Go deeper on CX Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CX Therapeutics.

Explore the full profile